PharmaMar and STA sign licensing agreement for APLIDIN® covering Asian countries

(Pharmamar) PharmaMar today announced an agreement with Singapore-based Specialised Therapeutics Asia Pte, Ltd (STA) to market marine-based anti-tumor compound APLIDIN® (plitidepsin) for the treatment of hematological tumors in 12 Asian countries.